Neuroscience Antibodies & Assays Market Intelligence Report Covers Trends, Segments And Regional Growth

The Business Research Company’s Neuroscience Antibodies & Assays Market Intelligence Report Covers Trends, Segments And Regional Growth

LONDON, GREATER LONDON, UNITED KINGDOM, August 19, 2026 /EINPresswire.com/ — “The neuroscience antibodies and assays sector is experiencing swift advancement, driven by growing research efforts and the rising prevalence of neurological diseases. This market is poised for significant expansion as innovations continue to enhance diagnostic capabilities and therapeutic research in neuroscience.

Neuroscience Antibodies and Assays Market Size and Expansion Outlook
The market for neuroscience antibodies and assays has witnessed rapid growth in recent years. It is projected to increase from $5.03 billion in 2025 to $5.76 billion in 2026, representing a compound annual growth rate (CAGR) of 14.5%. This expansion during the historical period is largely due to the rising prevalence of neurological disorders, increased funding for neuroscience research, more widespread use of immunoassays in diagnostics, advancements in laboratory instrumentation, and growth in academic neuroscience programs.

Download a free sample of the neuroscience antibodies & assays market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7548&type=smp&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Aug_PR

Future Growth Projections of the Neuroscience Antibodies and Assays Market
Looking ahead, the neuroscience antibodies and assays market is forecast to grow swiftly, reaching $9.83 billion by 2030 with a CAGR of 14.3%. This anticipated growth is driven by heightened investments in neurodegenerative disease research, rising demand for personalized diagnostic tools in neurology, expansion of drug discovery initiatives, growing adoption of automated assay platforms, and increased attention to early detection of neurological diseases. Key trends shaping the market during this period include the greater use of high-specificity antibody reagents, adoption of multiplex assay systems, integration of automation in neuroscience research laboratories, expansion of biomarker-based neurological studies, and a stronger focus on assay reproducibility and sensitivity.

Understanding the Role of Neuroscience Antibodies and Assays
Neuroscience antibodies and assays play a critical role in studying the development, structure, function, disorders, and degeneration of the nervous system. Neuroscience itself involves the examination of the nervous system’s workings and related diseases. Antibodies and assays are diagnostic tests based on the interaction between antigenic sites and antibodies, which are essential tools in neuroscience research and clinical diagnosis of neurological disorders.

View the full neuroscience antibodies & assays market report:
https://www.thebusinessresearchcompany.com/report/neuroscience-antibodies-and-assays-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Aug_PR

Key Factors Fueling Growth in the Neuroscience Antibodies and Assays Market
One of the primary drivers behind the expanding neuroscience antibodies and assays market is the rising incidence of neurological diseases. These disorders affect the brain, spinal cord, and peripheral nerves, resulting in impaired cognitive, motor, or sensory functions. The increase in neurological illnesses is closely linked to population aging, with a growing number of older adults in developed countries leading to higher rates of age-related conditions such as Alzheimer’s and Parkinson’s diseases. This trend boosts the demand for specialized antibodies and assays, as researchers and clinicians rely on these tools to detect, analyze, and monitor disease-specific biomarkers and protein abnormalities in neurological conditions.

Supporting Data on Rising Neurological Conditions
For example, in March 2023, the Alzheimer’s Association, a US-based nonprofit organization, reported that approximately 6.7 million Americans aged 65 and older were living with Alzheimer’s dementia in 2023. This number is expected to nearly double to 13.8 million by 2060. Such statistics emphasize how the growing prevalence of neurological diseases is a significant factor driving the neuroscience antibodies and assays market forward.

Dominant Market Region for Neuroscience Antibodies and Assays
In 2025, North America led the neuroscience antibodies and assays market in terms of size. The comprehensive market report also includes analysis of regions such as Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa, providing a global perspective on market dynamics.

Our 2026 reports feature deeper market intelligence with market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, and updated graphics and tables.

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info

The Business Research Company – www.thebusinessresearchcompany.com

Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company“

Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X

Media gallery

About The Author

Written By: EIN Presswire